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Mesenchymal stem cells 
Mesenchymal stem cell (MSCs) are 
non-hemotopoetic, multipotentent, adult 
stem cell. MSCs have ability to self-
renew and differentiate into multiple 
tissues, including bone, cartilage, fat, and 
other tissues of mesodermal origin. They 
are present in blood, adipose tissue, bone, 
skin and Wharton’s jelly (Maleki et al. 
2014).  
      The multidirectional therapeutic 
potential of MSCs has generated 
increasing amount of research in all over 
the world. It caused lack of homogenous 
methods in isolation, cell culture and 
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This review article provides an overview on adipose-derived stem cells 
(ADSCs) for implications in bone tissue regeneration. 
Firstly this article focuses on mesenchymal stem cells (MSCs) which are 
object of interest in regenerative medicine. Stem cells have unlimited 
potential for self-renewal and develop into various cell types. They are 
used for many therapies such as bone tissue regeneration. Adipose tissue 
is one of the main sources of mesenchymal stem cells (MSCs). 
Regenerative medicine intends to differentiate ADSC along specific 
lineage pathways to effect repair of damaged or failing organs. For 
further clinical applications it is necessary to understand mechanisms 
involved in ADSCs proliferation and differentiation.  
Second part of manuscript based on osteogenesis differentiation of stem 
cells. Bones are highly regenerative organs but there are still many 
problems with therapy of large bone defects. Sometimes there is 
necessary to make a replacement or expansion new bone tissue. Stem 
cells might be a good solution for this especially ADSCs which manage 
differentiate into osteoblast in in vitro and in vivo conditions. 
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identification of mesenchymal stem cells. 
It has forced The International Society 
for Cellular Therapy (ISCT) and 
International Federation for Adipose 
Therapeutics (IFATS) to creating a 
minimal criteria to define MSCs. Based 
on it human MSCs identified by 
adherence to plastic and expression of 
cell surface markers including CD90, 
CD73, CD105 and lack of expression of 
CD45, CD34, CD14 or CD11b, CD79a 
or CD19 and HLA-DR surface proteins. 
There also must differentiate to 
osteoblasts, adipocytes and chondroblasts 
in vitro condition (Dominici et al. 2006, 
Fathi et al. 2016, Bourin 2013)(Tab. 1).  
 
Table 1. Minimal criteria for defining mesenchymal stem cells. 
Feature 
cell culture adherence to plastic 
differentiation potential osteoblasts, adipocytes and chondroblasts 
≥ 95% population of cell with expression 
surface markers 
CD90, CD73, CD105 
≤ 2 % population of cell with lack of surface 
expression 
CD45, CD34, CD14 or CD11b, CD79a, CD19, 
HLA-DR 
 
It was proven that MSCs have 
inflammatory, immunomodulatory 
functions and they can penetrate into 
inflammatory sites. They secrete factors 
such as: TGF- β , IL-6, -7, -8, -10, 11,-
12, -14, inducible nitric oxide synthase 
(iNOS) and hemooxygenase (HO). MSCs 
can modulate immunological responses 
through T-cell-mediated (Takano et al. 
2014, Rahimzadeh et al. 2014) They 
release also multiple angiogenic and 
growth factors: VEGF, HGH or IGH-1 
(Fathi et al. 2016, Soulnier et al. 2010). It 
suggest that they are improving 
neovascularization and promote 
angiogenesis process (Abudusaimi et al. 
2011). 
Thus MSCs have been applied in 
various diseases connected with bone 
damages, for example: rheumatoid 
arthritis (Takano et al. 2014), avascular 
necrosis of the femoral head 
(Abudusaimi et al.2011) and large 
mechanical defects. 
 
Adipose derived stem cel 
Adipose tissue is one of the most 
richness source of stem cells. Adipose 
derived stem cells (ADSCs) are plastic-
adherent cells, which are characterized 
by a variety of cell surface markers 
(Undale et al. 2009). They were first 
described. in 2001 as a population of 
cells derived from adipose tissue with the 
potential of differentiation (Zuk et al. 
2001). Isolation method based on 
digested it with collagenase Type I, and 
separated the cellular components by 
centrifugation (Gimble et al. 2003). The 
number of cells after isolation is 
connected with amount of adipose tissue. 
The lowest amount of tissue is 0,1-2mg 
but the number of stem cells depend on 
tissue and their volume is associated with 
destination of ADSCs (Cheng et al. 
2011).  
ADSCs are able to differentiate into a 
number of mesenchymal cell types, 
including osteoblasts, chondrocytes and 
adipocytes (Undale et al. 2009, 
Fernandez et al. 2015).  
Compared to other types of stem 
cells, ADSCs have many advantages. 
ADSCs can be easily obtained from a 
donor. Adipose tissue donation is the 
easiest and less invasive for patients in 
comparison e.g. bone marrow biopsy. 
Procedure of liposuction can provide a 
lot of tissue and cells. Moreover isolation 
of stem cells from bone marrow is less 
effective and cells often are contaminate 
(Chen at al.2013, Fathi et al. 2016, Dai et 
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al. 2016). Comparison of mesenchymal 
stem cells obtained from different tissues 
(fat tissue, bone marrow, placenta) 
showed that adipose stem cells did not 
differ morphologically from bone 
marrow cells. These cells have similar 
expression of the main marker genes 
(Musina et al. 2005). 
It has been shown that from 1 gram of 
fat tissue may be isolated from 0.5 x 10
4
 
to 2 x 10
5
 stem cells. Differences in the 
amount are connected with a gender, age, 
body mass index of donor but also 
medical record, type of adipose tissue 
(white or brown)  and its location (Bajek 
et al. 2008, Olkowska et al. 2008). 
Research suggested that cells from 
younger donor are grown and 
differentiating better than from old 
donors (Bunnell et al. 2008, Musina et al. 
2005). 
Moreover there is not ethical 
problems with using ADSCs which is a 
huge issue for embryonal stem cell (Dai 
et al. 2016). 
The transcriptome analysis with 
microarray technique of ADSC were 
reveals their more adipogenic potential 
than osteogenic in compared to bone 
marrow stem cells (BMSC). They also 
have larger capability to lipid synthesis. 
It suggest that ADSCs indicate better 
ability to differentiation into adipocytes 
than osteoblast. The differences were 
related to MSCs location. However 
ADSCs show lower immunogenicity than 
stem cells in bone marrow. Moreover 
tissue harvesting is easy, quick and 
efficient and thus they seem to be a better 
alternative as a stem cells source in 
compared another tissues (Bionaz et al. 
2015, Monaco et al. 2012).  
However, different methods of 
isolation of adipose tissue have influence 
on expression profile of genes 
characteristic of ADSCs. Comparison of 
adipose tissue collected during the 
surgery and adipose tissue collected by 
liposuction have shown the bigger 
amount of cell in case of liposuction and 
the population of these cells was more 
homogenous. As a result, processes of 
differentiation of both types of cells to 
mesoderm (cartilage, osteoblasts and 
adipocytes) it was more efficient in cells 
isolated from lipoaspirate than biopsy 
(Gnanasegaran et al. 2014). There is not 
many results about colleting stem cells 
from different adipose tissue places. It 
suggested that difference in number of 
cells between subcutaneous adipose 
tissue from the arms in compared to 
abdomen and breast. The amount of 
adipose derived stem cell is connected 
with location, type and species. 
(Kolaparthy et al. 2015). 
The comparison of isolation adipose 
derived stem cells ADSC manual and 
automatic methods difference in cells 
activity did not observed. The number 
and viability of cells were similar in both 
cases (Doi et al. 2013). 
 
Methods of differentiation of stem cells 
Standard method for initiating 
osteogenic differentiation in stem cell 
culture is application some components 
which induce this process. Culture of 
MSCs in osteogenic medium causes 
manifestation of osteoblasts markers 
(Birmingham et al. 2012). Basic 
substances with proved action on 
osteogenesis in stem cells are: 
dexamethasone (Dex), ascorbic acid 
(Asc) and β-glycerophosphate (β-Gly). 
For osteogenic differentiation at least 21 
days of treatment this substances are 
necessary (Langenbach et al.2013). 
Mechanism of induces osteogenesis 
process by dexamethasone is 
multidirectional. Dex induces 
differentiation into osteoblast by 
activating Wnt/β-catenin pathways. It 
indicated that by Four And A Half LIM 
Domains 2 (FHL2) upregulation which 
influence on expression of RUNX2. 
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Consequently expression of collagen type 
I alpha 1 (COL1A1) is also upregulated. 
Moreover dexamethasone regulates the 
function of  RUNX2 via the activity of 
molecule TAZ which is transcriptional 
coactivator with PDZ-binding motif and 
mitogen-activated protein kinase 
(MAPK) phosphatase (MPK-1).  
Bone morphogenetic protein (BMP) 
signaling also change the activity 
RUNX2 which was connected with 
initiating osteogenesis process. Binding 
BMPs to their receptors causes of 
phosphorylation SMAD proteins (SMAD 
2, SMAD 5 and SMAD8) which 
subsequently bind with SMAD 4 and 
after translocation to nucleus regulates 
the expression of osteogenic transcription 
factors as RUNX2, OSX and DLX. 
Experiments showed that optimal 
concentration of dexamethasone in 
medium culture is 10nm (Langenbach et 
al. 2013). 
Ascorbic acid induce differentiation 
of stem cells through the enhancement 
secretion of collagen type I into the 
extracellular matrix (ECM). It is a 
cofactor for hydroxylate proline and 
lysine which they are required for 
transformation pro-collagen into active 
form. β-glycerophosphate is a phosphate 
source in mineralization process and it 
induce expression of genes connected 
with osteogenesis through 
phosphorylation of kinases (Langenbach 
et al. 2013). 
Numerus studies showed the relevant 
impact of vascular endothelial growth 
factor on the osteogenesis (Behr et al. 
2011, Clark et al. 2015). VEGFA 
promotes the differentiation of progenitor 
cells into the direction of factors 
associated with angiogenesis, but also it 
impacts on the cells from bone tissue. 
VEGFA is one of the most important 
mediators of angiogenesis, cell migration 
and mineralization (Clark et al. 2015). It 
is extremely important element of 
osteogenesis due to bone vascularization 
during its expansion and repair (Behr et 
al. 2011). It was also noticed that the 
strong relationship occurs with VEGF 
factor and the bone morphogenetic 
proteins pathway. BMPs induces the 
intracellular signals which causes the 
differentiation of progenitor cells into 
osteoblasts (Zhang et al.2012). The 
treatment of ADSC with VEGF and 
BMP6 in vitro caused the increase in 
expression of alkaline phosphatase, genes 
associated with osteogenesis e.g. 
collagen type 1 (COL1A1), the osterix 
transcription factor and gene which 
encodes the homeotic protein DLX5 
(distal-less homeobox 5) and also cells 
mineralization (Zhang et al.2012, Clark 
et al. 2015, Li and Madhu et al.2015, Li 
and Liu et al. 2015). Similar effect was 
observed both in the case of simultaneous 
treatment of ADSC with VEGF and 
BMP2, 4 and 9 (Zhang et al.2012, Li and 
Liu et al. 2015). Besides the use of 
VEGF and fibroblast growth factor 
(FGF-2) caused only the initiation of 
angiogenesis (Clark et al. 2015). 
Experiments suggest also application 
of active form of 1,25(OH)2 D3 vitamin 
as the induction factor of osteogenesis 
(Kato et al. 2015). It was shown that 
there is possibility of generation both the 
osteoblasts and the cells similar to 
osteocytes from induced pluripotent cells 
inter alia by the supplementation with 
1,25(OH)2 D3 vitamin (Kato et al. 2015). 
Another factor showing the impact on 
differentiation of stem cells derived from 
adipose tissue is the hypoxia. It was 
noticed that the culture of ADSC in the 
conditions with the low level of oxygen 
(1-2%) strengthens the survivability and 
proliferation of the cells. This state 
intensifies the potential of differentiation 
into osteoblasts and also strengthens the 
expression of genes responsible for the 
maintenance of stemness: OCT4 
(octamer-binding transcription factor 4), 
FOLIA BIOLOGICA ET OECOLOGICA 
 
 
ADSCS: A REVIEW OF OSTEOGENESIS DIFFERENTIATION 42 
NANOG (transcription factor), KLF4 
(Kruppel-like factor 4) (Valorani et al. 
2012, Xu et al. 2014). 
The increase of genes associated with 
angiogenesis, adhesion and the growth 
factor releasement was also documented. 
Probably, it is the effect of physiological 
presence of low concentration of the 
oxygen at the stem cells niche (Valorani 
et al. 2012, Xu et al. 2014). Another 
study showed that the hypoxia weakens 
the proliferation ability of MSC but does 
not influences on the phenotype and 
seems to maintain them in the more 
immature stage than at the standard 
culture. This state caused the increase in 
pluripotent gene expression: SOX2 (SRY 
sex determining region Y-box 2), 
NANOG, OCT-4 (Ranera et al 2012).  
The hormone participating in the 
regulation of glucose homeostasis in 
organism is the glucagon-like peptide 
type 1 (GLP-1). The use of GLP-1 in 
culture medium cause the increase in 
mRNA expression of markers specific to 
osteoblasts, the activity of alkaline 
phosphatase and mineralization of 
calcium. This hormone is especially 
important in insulin secretion by glucose-
dependent pathway and has the anti-
diabetic impact in the treatment of type 2 
diabetes. Additionally, patients with 
diabetes have a higher risk for bone 
fracture and osteoporosis, which proves 
about close relationship which 
osteogenesis and the activity of GLP-1 
hormone and the disruption of 
carbohydrate economy (Lee et al. 2015). 
Estrogens acts also an important role 
at the formation of bone structure. The 
characteristic changes in the level of 
estrogens in the perimenopausal period 
causes osteoporosis, therefore numerus 
study suggest the use estrogens in the 
osteogenesis of the stem cells (Gao et al. 
2015, Veronesi et al. 2015) (Tab. 2).
Table 2. Methods of differentiation of stem cells. 
Differentiating factors References 
dexamethasone (Dex), 
ascorbic acid (Asc), 
β-glycerophosphate (β-Gly) 
Langenbach et al.2013 
vascular endothelial growth factor (VEGF) 
Behr et al. 2011 
Clark et al. 2015 
Li and Madhu et al.2015 
Zhang et al.2012 
bone morphogenetic protein (BMP) 
Zhang et al.2012 
Clark et al. 2015 
Li and Madhu et al.2015 
Li and Liu et al. 2015 
transforming growth factor (TGF-β) Li and Liu et al. 2015 
active form of 1,25(OH)2 D3 vitamin  Kato et al. 2015 
hypoxia 
Valorani et al. 2012 
Xu et al. 2014 
Ranera et al. 2012 
glucagon-like peptide type 1 (GLP-1).  Lee et al. 2015 
estrogens 
Gao et al. 2015 
Veronesi et al. 2015 
 
Mechanism of osteogenesis stem cells 
Treatment of large bone defects and 
incurable fractures is difficult clinical 
problem. Adipose tissue stem cells have 
ability to regenerate damaged bone 
tissue. However, there are necessary 
coexistence of efficient processes of 
angiogenesis and osteogenesis extending 
in order of their use (Behr et al. 2011). 
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The process of the osteogenesis of the 
stem cells derived from adipose tissue is 
regulated by the transcription of 
numerous genes. It should be noted, that 
in case of adipogenesis and osteogenesis 
the receptor proteins are activated by the 
PPAR (peroxisome proliferator-activated 
receptors). At the side of osteogenesis, 
these proteins acts as the negative 
regulator. The central role in this process 
is acted by the Wnt and PI3K/AKT and 
also the MAPK (mitogen-activated 
protein kinases) pathways (Bionaz et al. 
2015, Chen and Shi et al. 2013). During 
the osteogenesis lots of growth factors 
such as bone morphogenic proteins 
(BMP), fibroblast growth factor (FGF), 
transforming growth factor beta (TGFβ), 
platelet-derived growth factor (PDGF) 
and the vascular endothelial growth 
factor (VEGF) are secreted (Li and 
Madhu et al. 2015). The regulation of the 
majority of these factors is based on 
noncoding activity of micro RNA 
(miRNA) (Oshita et al. 2011, Chen et al. 
2013). 
The impact study of the interleukin 
family (IL-1) on the MSC confirmed its 
induction of the osteogenesis of human 
mesenchymal stem cells. It was proved 
that IL-1 activates the Wnt pathway i.e. 
the Wnt-5a gene and its orphan receptor 
of tyrosine-protein transmembrane 
receptor (ROR2). Similar effect was 
noted in the presence of cytokines such 
as interleukin-6 family (IL-6) and the 
tumor necrosis factor alpha (TNFα), 
besides with weaker effects of 
differentiation (Sonomoto et al. 
2012,Tanaka 2015). 
The differentiation of stem cells in 
vitro into the cells of bone tissue is multi-
stage. In the first step, which is ongoing 
from five to fourteen days the expression 
of alkaline phosphatase (ALP) both at the 
level of transcriptome and proteome. 
ALP is known as reliable marker of early 
osteoblast differentiation (Clark et al. 
2015). Additionally, at the early stage, 
the expression of collagen type 1 also 
increases and then the ALP level 
decreases. At the next stage which is 
ongoing from about fourteen to twenty-
eight day increases the expression of 
osteocalcin an osteopontin (Birmingham 
et al. 2012) 
To fully knowledge of differentiation 
mechanisms of stem cells into the 
osteoblasts will allow to maximize the 
use of this process in regenerative 
medicine. 
 
3D culture of ADSC in regeneration of 
bone defects 
ADSCs have shown promising results in 
many diseases. However positive results 
of experiments in two-dimensional plate 
culture are not meaningful, because of 
not sufficient condition of environment, 
without cell-cell and cell-environment 
interaction. The development of tissue 
and biomaterials engineering in last years 
resulted in a significant improvement of 
regenerative medicine and three-
dimensional scaffolds are used more 
widely Three-dimensional cells culture 
techniques initiate cellular 
microenvironment similar to in vivo. 3D 
scaffolds have many advantages in 
compared to 2D culture. It observed that 
they can enhance the cell viability during 
proliferation (Dai et al.2016, ) 
Scaffolds are produced using 
biomaterials from selected components; 
they must be biocompatible and do not 
cause immune reaction. Their 
mechanical, chemical properties and 
microstructural patterns must be adapted 
to cell line. Scaffolds can be also 
biodegradable and non-biodegradable. It 
depends on its destination. Many studies 
indicate that ADSCs culture in 3D 
scaffolds can be alternative treatment in 
orthopaedic tissue repair (Dai et al. 
2016). Nowadays traditional autologous 
and allogenous bone grafts are replacing 
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by different biomaterials. It is caused by 
lack of donor, potential disease 
transmission and severe immunogenic 
responses (Zhang et al. 2013). 
Polylactic acid polymer scaffolds 
have the advantage of being degradable, 
porosity and easily moldable. It was 
found that polypyrrole-coated polylactide 
scaffolds can provide higher alkaline 
phosphatase (ALP) activity levels, which 
benefit the early osteogenic 
differentiation of ADSCs (Dai et al. 
2016). Experiments show that PLA 
scaffolds escalate angiogenesis and 
osteogenesis of adipose derived stem 
cells but with co-culture with osteoblast 
or endothelial cell. It helps to create cell-
cell interaction (Shah et al. 2014). These 
scaffolds provide properly growth and 
osteogenic differentiation of adipose  
derived stem cells (Lu et al. 2014). 
Chitosan is one of the substance which is 
examined for using in regenerative 
medicine of bone damage . It can be used 
as 2D or 3D scaffolds which have many 
advantages like: porosity, non-toxic and 
biocompatibility, high adsorption 
capacity and biodegradability (Busilacchi 
et al. 2013, Dash et al. 2011). 
 
Conclusions 
Adipose tissue is rich source of stem 
cells. ADSCs have multidirectional 
potential to differentiation inter alia into 
bone tissue. Development of regenerative 
medicine help in treatment large bone 
defects and their metabolism disorders. 
Unfortunately stem cells still must be 
examined for the safety of potential 
patients. Problems are inefficient 
differentiation, optimization of 
osteogenic medium and also 
comorbidities influence on proliferation 
and metabolism of stem cells.
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Komórki macierzyste to komórki posiadające zdolność nieograniczonych 
podziałów oraz  umiejętność  do  wielokierunkowego  różnicowania.  Mezenchymalne  
komórki macierzyste  (MSC)  to  somatyczne  komórki  występujące  w  tkankach  i  
narządach dorosłego  organizmu  takich  jak:  szpik  kostny,  tkanka  tłuszczowa  oraz  
mięśnie. Ulegają  one  różnicowaniu  w  kierunku  komórek  pochodzących  z  jednego  
listka zarodkowego jakim jest mezoderma. To pozwala na wykorzystanie ich w 
regeneracji chrząstki,  kości  lub  wypełnienia  ubytków  tkanką  tłuszczowa  między  
innymi  w chirurgi plastycznej.  
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Obecnie  głównym  źródłem  z  którego  pozyskiwano  MSC  był  szpik  kostny,  
jednak coraz szersze zastosowanie wykazuje tkanka tłuszczowa. Komórki z niej 
pochodzące wykazują takie same właściwości jak te pochodzące z szpiku kostnego, a 
procedura izolacji jest dużo mniej inwazyjna dla pacjenta. Bardzo często natomiast ich 
ilość jest nieporównywanie większa. Stąd  też  niniejsza  praca  porusza  temat  
wykorzystania  MSC  z  tkanki  tłuszczowej  w regeneracji tkanki kostnej. 
